Rothschild group, Pasteur Institute wrap up $60m for Israeli-oriented biotech fund

The Compagnie Financière Edmond de Rothschild, of the Rothschild banking group, and the Pasteur Institute are wrapping up a $60 million financing round for biotechnology investments.

The fund, BioDiscovery 2, will target both European and Israeli biotechnology endeavors, Professor Max Herzberg told TheMarker today.

The first BioDiscovery fund had invested in three Israeli firms.

BioDiscovery Israel, run by Herzberg, is contending for the biotechnology incubator tender issued by the Israeli Ministry of Industry and Trade. The tender is for the management of two biotechnology incubators.

Herzberg also chairs the Eager Biogroup incubator in Ashdod, and is a partner in running the Biotop biotechnology incubator of the Pasteur Institute in Paris together with Dr Christian Policard.